Skip to main content
Fig. 3 | AIDS Research and Therapy

Fig. 3

From: Renal function in Japanese HIV-1-positive patients who switch to tenofovir alafenamide fumarate after long-term tenofovir disoproxil fumarate: a single-center observational study

Fig. 3

A Changes in BMI (mean ± SE) of the patients taking TAF after taking TDF for more than 48 weeks. B Changes in TG (mean ± SE) of the patients taking TAF after taking TDF for more than 48 weeks. TDF: tenofovir disoproxil fumarate; TAF: tenofovir alafenamide fumarate; TDF0: start of TDF; TAF0: start of TAF; TAF12, -24, -48, -96, and -144: 12 weeks, 24 weeks, 48 weeks, 96 weeks, and 144 weeks after starting TAF. *p < 0.05 is defined as a significant difference by the paired t-test

Back to article page